|
On January 25th IBM and Ricoh announced the formation of a joint venture company
based on IBM's Printing Systems Division.
The joint venture will be called the InfoPrint Solutions Company.
Ricoh initially will acquire 51 percent of the joint venture and will progressively
acquire the remaining 49 percent over the next three years as the joint venture
evolves into a fully owned subsidiary of Ricoh.
Ricoh will provide the investment necessary for the InfoPrint Solutions Company
to continue to innovate and grow, which will benefit current and future customers.
The eventual transfer of the IBM Printing Systems Division to Ricoh enables IBM
to continue to refine its focus on its strategic businesses and the clients of
those businesses, including print and output solutions for enterprises.
See the
January 25th press release
for more details.
System z and System i print software is not part of the transfer and
IBM continues to own these products.
The following is an abbreviated listing of the System z and System i print
software products that IBM continues to own:
- System z products: Print Services Facility for z/OS, Infoprint Server and
Infoprint Transforms for z/OS, Page Printer Formatting Aid (PPFA),
Overlay Generation Language (OGL), Infoprint for z/OS Fonts, AFP Font Collection
for S/390, Infoprint XT Extender for z/OS, Infoprint XML Extender for z/OS,
Print Services Facility for VSE and VM, Document Composition Facility (DCF),
AFP Toolbox for MVS, and DLF (Document Library Facility)
- System i products: Infoprint Server for iSeries, Print Services Facility for
i5/OS, Infoprint Designer for iSeries, AFP Font Collection for AS/400, and
AFP Utilities for iSeries.
Customers will continue to receive new products, support, service, and
enhancements through IBM.
Customers may continue to get product and ordering information for these products at:
IBM, Ricoh, and the new InfoPrint Solutions Company will collaborate
to deliver output solutions that can address complex and mission critical environments
Contact z/OS
Send us your questions and comments.
|
